POSTMENOPAUSAL WOMEN OSTEOPOROSIS

Clinical trials for POSTMENOPAUSAL WOMEN OSTEOPOROSIS explained in plain language.

Never miss a new study

Get alerted when new POSTMENOPAUSAL WOMEN OSTEOPOROSIS trials appear

Sign up with your email to follow new studies for POSTMENOPAUSAL WOMEN OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a biosimilar match prolia in strengthening bones?

Disease control Completed

This trial tests whether an experimental biosimilar called 9MW0311 works as well as the established drug Prolia (both containing denosumab) in postmenopausal women with osteoporosis who are at high risk for fractures. Participants receive either 9MW0311 or Prolia as an injection …

Matched conditions: POSTMENOPAUSAL WOMEN OSTEOPOROSIS

Phase: PHASE3 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

POSTMENOPAUSAL WOMEN OSTEOPOROSIS

Get alerted when new POSTMENOPAUSAL WOMEN OSTEOPOROSIS trials appear

Can a biosimilar match prolia in strengthening bones?